Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination regimens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback